Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)
{{output}}
Alternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers transcriptomic plasticity and proteomic diversity in cancer, thereby enabling tumor adaptation to therapeutic pressure. However, two obstacles impede ... ...
